These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 37523743)
1. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome. Chen A; Lan Z; Li L; Xie L; Liu X; Yang X; Wang S; Liang Q; Dong Q; Feng L; Li Y; Ye Y; Fu M; Lu L; Yan J Cardiovasc Res; 2023 Oct; 119(13):2368-2381. PubMed ID: 37523743 [TBL] [Abstract][Full Text] [Related]
2. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals. Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382 [TBL] [Abstract][Full Text] [Related]
3. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Pang Q; Wang P; Pan Y; Dong X; Zhou T; Song X; Zhang A Cell Death Dis; 2022 Mar; 13(3):283. PubMed ID: 35354793 [TBL] [Abstract][Full Text] [Related]
4. Hao QY; Yan J; Wei JT; Zeng YH; Feng LY; Que DD; Li SC; Guo JB; Fan Y; Ding YF; Zhang XL; Yang PZ; Gao JW; Li ZH Gut Microbes; 2024; 16(1):2351532. PubMed ID: 38727248 [TBL] [Abstract][Full Text] [Related]
5. Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation. Li XX; Chen ZD; Sun XJ; Yang YQ; Jin H; Liu NF Acta Pharmacol Sin; 2024 Apr; 45(4):751-764. PubMed ID: 38172306 [TBL] [Abstract][Full Text] [Related]
6. Canagliflozin inhibits inflammasome activation in diabetic endothelial cells - Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells. Li X; Kerindongo RP; Preckel B; Kalina JO; Hollmann MW; Zuurbier CJ; Weber NC Biomed Pharmacother; 2023 Mar; 159():114228. PubMed ID: 36623448 [TBL] [Abstract][Full Text] [Related]
7. VX-765 ameliorates CKD VSMC calcification by regulating STAT3 activation. Duan Y; Peng Z; Zhong S; Zhou P; Huang H; Li J; He Z Eur J Pharmacol; 2023 Apr; 945():175610. PubMed ID: 36858340 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of HDAC9 by the ketone metabolite β-hydroxybutyrate suppresses vascular calcification. Lan Z; Chen A; Li L; Ye Y; Liang Q; Dong Q; Wang S; Fu M; Li Y; Liu X; Zhu Z; Ou JS; Qiu X; Lu L; Yan J J Pathol; 2022 Nov; 258(3):213-226. PubMed ID: 35894849 [TBL] [Abstract][Full Text] [Related]
9. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation. Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease. Yang X; Chen A; Liang Q; Dong Q; Fu M; Liu X; Wang S; Li Y; Ye Y; Lan Z; Ou JS; Lu L; Yan J Free Radic Biol Med; 2021 Aug; 172():530-540. PubMed ID: 34174395 [TBL] [Abstract][Full Text] [Related]
11. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Ye Y; Chen A; Li L; Liang Q; Wang S; Dong Q; Fu M; Lan Z; Li Y; Liu X; Ou JS; Lu L; Yan J Kidney Int; 2022 Dec; 102(6):1259-1275. PubMed ID: 36063875 [TBL] [Abstract][Full Text] [Related]
12. Implication of M2 macrophage on NLRP3 inflammasome signaling in mediating the neuroprotective effect of Canagliflozin against methotrexate-induced cognitive impairment. Khedr LH; Rahmo RM; Eldemerdash OM; Helmy EM; Ramzy FA; Lotfy GH; Zakaria HA; Gad MM; Youhanna MM; Samaan MH; Thabet NW; Ghazal RH; Rabie MA Int Immunopharmacol; 2024 Mar; 130():111709. PubMed ID: 38377857 [TBL] [Abstract][Full Text] [Related]
13. Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 dependent osteogenic reprogramming. Wu S; Luo X; Chen Y; Wang Z; Liu X; Sun N; Zhao J; Luo W; Zhang J; Tong X; Huang L; Liu C; Qin Z Redox Biol; 2024 Jul; 73():103183. PubMed ID: 38759418 [TBL] [Abstract][Full Text] [Related]
14. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease. Li W; Feng W; Su X; Luo D; Li Z; Zhou Y; Zhu Y; Zhang M; Chen J; Liu B; Huang H J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34793336 [TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis. Long Q; Li L; Yang H; Lu Y; Yang H; Zhu Y; Tang Y; Liu C; Yuan J Int Immunopharmacol; 2022 Sep; 110():109024. PubMed ID: 35841866 [TBL] [Abstract][Full Text] [Related]
16. Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease. Jiang W; Ruan W; Wang Z FASEB J; 2022 Sep; 36(9):e22504. PubMed ID: 35980507 [TBL] [Abstract][Full Text] [Related]
17. FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway. Heng Y; Wei W; Cheng L; Wu F; Dong H; Li J; Fu J; Yang B; Liang X; Liu C; Li H; Liu H; Zhang P Acta Biochim Biophys Sin (Shanghai); 2024 Jun; 56(6):892-904. PubMed ID: 38733164 [TBL] [Abstract][Full Text] [Related]
18. Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Huang S; Wu B; He Y; Qiu R; Yang T; Wang S; Lei Y; Li H; Zheng F Hepatol Commun; 2023 Mar; 7(3):e0045. PubMed ID: 36757426 [TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis. Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice. Wei W; Li XX; Xu M Atherosclerosis; 2019 Oct; 289():132-142. PubMed ID: 31513948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]